Xavier Girerd

13.2k total citations · 4 hit papers
181 papers, 8.8k citations indexed

About

Xavier Girerd is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xavier Girerd has authored 181 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Cardiology and Cardiovascular Medicine, 35 papers in Surgery and 31 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xavier Girerd's work include Blood Pressure and Hypertension Studies (87 papers), Cardiovascular Health and Disease Prevention (50 papers) and Hormonal Regulation and Hypertension (22 papers). Xavier Girerd is often cited by papers focused on Blood Pressure and Hypertension Studies (87 papers), Cardiovascular Health and Disease Prevention (50 papers) and Hormonal Regulation and Hypertension (22 papers). Xavier Girerd collaborates with scholars based in France, United States and Spain. Xavier Girerd's co-authors include Michel E. Safar, Jean‐Jacques Mourad, Pierre Boutouyrie, Jacques Blacher, Mark A. Creager, John P. Cooke, Paul Milliez, Pierre‐François Plouin, Olivier Hanon and Patrick Lacolley and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Investigation.

In The Last Decade

Xavier Girerd

173 papers receiving 8.4k citations

Hit Papers

Evidence for an increased rate of cardiovascular ... 1989 2026 2001 2013 2005 1998 1992 1989 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
    2005 1.1k citations Paul Milliez, Xavier Girerd et al. Journal of the American College of Cardiology profile →
  2. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
    1998 1.0k citations Xavier Girerd et al. profile →
  3. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans.
    1992 670 citations Xavier Girerd et al. profile →
  4. Pulsatile versus steady component of blood pressure: a cross-sectional analysis and a prospective analysis on cardiovascular mortality.
    1989 413 citations Xavier Girerd, Michel E. Safar et al. Hypertension profile →

Peers

Xavier Girerd
Vasilios Papademetriou United States
Abraham A. Kroon Netherlands
Hisatomi Arima Japan
A. Richey Sharrett United States
Kazuyuki Shimada Japan
Francesca Mallamaci Italy
Tetsuo Shoji Japan
Anton H. van den Meiracker Netherlands
Jacqueline C.M. Witteman Netherlands
Gilbert L’Italien United States
Vasilios Papademetriou United States
Xavier Girerd
Citations per year, relative to Xavier Girerd Xavier Girerd (= 1×) peers Vasilios Papademetriou

Countries citing papers authored by Xavier Girerd

Since Specialization
Citations

This map shows the geographic impact of Xavier Girerd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Girerd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Girerd more than expected).

Fields of papers citing papers by Xavier Girerd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Girerd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Girerd. The network helps show where Xavier Girerd may publish in the future.

Co-authorship network of co-authors of Xavier Girerd

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Girerd. A scholar is included among the top collaborators of Xavier Girerd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Girerd. Xavier Girerd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laurent, Stéphane, Gilles Châtellier, Michel Azizi, et al.. (2021). SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk. Hypertension. 78(4). 983–995. 51 indexed citations
2.
Gallo, Antonio, Thomas Dietenbeck, Alain Giron, et al.. (2020). Non-invasive evaluation of retinal vascular remodeling and hypertrophy in humans: intricate effect of ageing, blood pressure and glycaemia. Clinical Research in Cardiology. 110(7). 959–970. 9 indexed citations
3.
Dufay, Alexandre, Antonio Gallo, Olivier Hanon, B. Vaı̈sse, & Xavier Girerd. (2018). The repercussion of stopping reimbursement of olmésartan on antihypertensive drugs prescription and blood pressure control of treated hypertensive patients in France. Annales de Cardiologie et d Angéiologie. 67(3). 149–153. 3 indexed citations
4.
Girerd, Xavier, Olivier Hanon, & B. Vaı̈sse. (2018). Utilisation de l’échelle d’observance EvalObs ® dans une population de sujets traités pour une hypertension, une dyslipidémie ou un diabète : enquête FLAHS observance 2017. Annales de Cardiologie et d Angéiologie. 67(3). 186–190. 5 indexed citations
5.
Lim, Heng Siong, et al.. (2016). Conséquences de la réalisation du test ExSel® sur la consommation excessive de sel chez des patients hypertendus suivis en médecine générale. Annales de Cardiologie et d Angéiologie. 65(3). 142–145. 1 indexed citations
6.
Denolle, Thierry, et al.. (2016). Management of resistant hypertension: expert consensus statement from the French Society of Hypertension, an affiliate of the French Society of Cardiology. Journal of Human Hypertension. 30(11). 657–663. 12 indexed citations
7.
Hékimian, Guillaume, Nicolas Bréchot, Matthieu Schmidt, et al.. (2016). Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Annals of Intensive Care. 6(1). 117–117. 37 indexed citations
8.
Blacher, Jacques, Jean‐Michel Halimi, Olivier Hanon, et al.. (2014). Prise en charge de l’hypertension artérielle de l’adulte. 20(1). 39–47. 2 indexed citations
9.
Montalescot, Gilles, Philippe Cluzel, Atul Pathak, et al.. (2013). TCT-123 Preliminary safety and efficacy results from the REALISE trial: REnAL denervatIon by ultraSound transcatheter Emission. Journal of the American College of Cardiology. 62(18). B40–B40. 3 indexed citations
10.
Rosenbaum, David, Philippe Giral, John Chapman, et al.. (2013). Radial augmentation index is a surrogate marker of atherosclerotic burden in a primary prevention cohort. Atherosclerosis. 231(2). 436–441. 46 indexed citations
11.
12.
Rump, L. C., Xavier Girerd, Lorenz Sellin, & Johannes Stegbauer. (2010). Effects of high dose olmesartan medoxomil plus hydrochlorothiazide on blood pressure control in patients with grade 2 and grade 3 hypertension. Journal of Human Hypertension. 25(9). 565–574. 17 indexed citations
13.
Kjeldsen, Sverre E., Gordon T. McInnes, Giuseppe Mancia, et al.. (2008). Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: The VALUE trial. Blood Pressure. 17(3). 170–177. 10 indexed citations
14.
Mourad, Jean‐Jacques, Xavier Girerd, Paul Milliez, et al.. (2008). Urinary Aldosterone-to-active-renin Ratio: A Useful Tool for Predicting Resolution of Hypertension After Adrenalectomy in Patients With Aldosterone-producing Adenomas. American Journal of Hypertension. 21(7). 742–747. 22 indexed citations
15.
Cohen‐Aubart, Fleur, et al.. (2007). [Prevalence of sleep apnea in men with metabolic syndrome and controlled hypertension].. PubMed. 100(8). 637–41. 6 indexed citations
16.
Mourad, Jean‐Jacques, et al.. (2007). [Number and use of home blood pressure devices in France in 2004 and 2006 (FLAHS 2006)].. PubMed. 100(8). 620–4. 2 indexed citations
17.
Benner, Joshua S., Leif Erhardt, Zbigniew Gaciong, et al.. (2007). Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT). Contemporary Clinical Trials. 28(5). 662–673. 10 indexed citations
18.
Ducher, Michel, Catherine Cerutti, André F. Marquand, et al.. (2005). How to limit screening of patients for atheromatous renal artery stenosis in two-drug resistant hypertension?. Journal of Nephrology. 18(2). 161–165. 6 indexed citations
19.
Mourad, Jean‐Jacques, D Herpin, Nicolas Postel‐Vinay, et al.. (2005). [Use of home blood pressure devices in France in 2004].. PubMed. 98(7-8). 779–82. 3 indexed citations
20.
Safar, Michel E., Xavier Girerd, & S. Laurent. (1996). Structural changes of large conduit arteries in hypertension. Journal of Hypertension. 14(5). 545–555. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vasilios Papademetriou Breakdown of academic impact, for papers by Abraham A. Kroon Breakdown of academic impact, for papers by Hisatomi Arima Breakdown of academic impact, for papers by A. Richey Sharrett Breakdown of academic impact, for papers by Kazuyuki Shimada Breakdown of academic impact, for papers by Francesca Mallamaci Breakdown of academic impact, for papers by Tetsuo Shoji Breakdown of academic impact, for papers by Anton H. van den Meiracker Breakdown of academic impact, for papers by Jacqueline C.M. Witteman Breakdown of academic impact, for papers by Gilbert L’Italien
Rankless by CCL
2026